Feedback / Questions
panobinostat (MTX110) - Biodexa Pharma
https://www.globenewswire.com/news-release/2024/01/22/2813041/0/en/Biodexa-CEO-Issues-Shareholder-Letter-Highlighting-Progress-in-2023-and-Expected-Milestones-in-2024.html
Jan 22, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next